Page last updated: 2024-08-21

dihydroergotamine and Headache Disorders

dihydroergotamine has been researched along with Headache Disorders in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (50.00)29.6817
2010's3 (30.00)24.3611
2020's2 (20.00)2.80

Authors

AuthorsStudies
Antonelli, RC; Minster, A; Sant, J; Shapiro, HFJ1
Cahill, JE; Forbes, P; Schenkel, SR; Srouji, R1
Bale, JF; Kerr, LM; Nelson, GR1
Friedman, BW; Grosberg, BM1
Charles, JA; von Dohln, P1
Lovell, BV; Marmura, MJ1
Dodick, D; Eross, E; Gladstone, J1
Lisotto, C; Maggioni, F; Mainardi, F; Zanchin, G1
Erlanger, L; Leach, L; McPherson, V1
Charles, JA; Jotkowitz, S1

Reviews

3 review(s) available for dihydroergotamine and Headache Disorders

ArticleYear
Diagnosis and management of the primary headache disorders in the emergency department setting.
    Emergency medicine clinics of North America, 2009, Volume: 27, Issue:1

    Topics: Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Dihydroergotamine; Dopamine Agonists; Emergency Service, Hospital; Headache Disorders; Health Services Misuse; Humans; Patient Admission; Patient Discharge; Recurrence; Tryptamines; Valproic Acid

2009
New therapeutic developments in chronic migraine.
    Current opinion in neurology, 2010, Volume: 23, Issue:3

    Topics: Analgesics; Anticonvulsants; Botulinum Toxins, Type A; Dihydroergotamine; Electric Stimulation Therapy; Headache Disorders; Humans; Migraine Disorders; Neuropharmacology; Preventive Medicine; Risk Factors

2010
Clinical inquiries. What is the best treatment for analgesic rebound headaches?
    The Journal of family practice, 2005, Volume: 54, Issue:3

    Topics: Analgesics; Analgesics, Non-Narcotic; Anti-Inflammatory Agents; Dihydroergotamine; Headache Disorders; Humans; Serotonin Receptor Agonists; Withholding Treatment

2005

Trials

2 trial(s) available for dihydroergotamine and Headache Disorders

ArticleYear
Outpatient home-based continuous intravenous dihydroergotamine therapy for intractable migraine.
    Headache, 2010, Volume: 50, Issue:5

    Topics: Adolescent; Adult; Analgesics, Non-Narcotic; Dihydroergotamine; Female; Headache Disorders; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Migraine Disorders; Pain, Intractable; Prospective Studies; Young Adult

2010
Observations of the "carry-over effect" following successful termination of chronic migraine in the adolescent with short-term dihydroergotamine, dexamethasone and hydroxyzine: a pilot study.
    The journal of headache and pain, 2005, Volume: 6, Issue:1

    Topics: Administration, Oral; Adolescent; Adult; Age Factors; Anti-Inflammatory Agents; Brain; Chronic Disease; Dexamethasone; Dihydroergotamine; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Headache Disorders; Histamine H1 Antagonists; Humans; Hydroxyzine; Infusions, Parenteral; Male; Migraine Disorders; Pilot Projects; Treatment Outcome; Vasoconstrictor Agents

2005

Other Studies

5 other study(ies) available for dihydroergotamine and Headache Disorders

ArticleYear
Development and Evaluation of an Integrated Outpatient Infusion Care Model for the Treatment of Pediatric Headache.
    Pediatric neurology, 2022, Volume: 127

    Topics: Adolescent; Ambulatory Care; Child; Dihydroergotamine; Feasibility Studies; Headache Disorders; Humans; Models, Organizational; Process Assessment, Health Care; Quality Improvement; Referral and Consultation; Vasoconstrictor Agents; Workflow

2022
Dihydroergotamine infusion for pediatric refractory headache: A retrospective chart review.
    Headache, 2021, Volume: 61, Issue:5

    Topics: Administration, Intravenous; Adolescent; Child; Child, Preschool; Dihydroergotamine; Female; Headache Disorders; Humans; Male; Retrospective Studies; Treatment Outcome; Young Adult

2021
Outcome and Cost of Inpatient Hospitalization for Intravenous Dihydroergotamine Treatment of Refractory Pediatric Headache.
    Pediatric neurology, 2017, Volume: 66

    Topics: Administration, Intravenous; Adolescent; Analgesics, Non-Narcotic; Child; Dihydroergotamine; Female; Follow-Up Studies; Headache Disorders; Health Care Costs; Hospitalization; Hospitals, Pediatric; Humans; Inpatients; Male; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult

2017
Chronic daily headache: a rational approach to a challenging problem.
    Seminars in neurology, 2003, Volume: 23, Issue:3

    Topics: Adult; Antiemetics; Blood Patch, Epidural; Clinical Protocols; Cluster Headache; Diagnosis, Differential; Dihydroergotamine; Drug Therapy, Combination; Evidence-Based Medicine; Female; Follow-Up Studies; Headache Disorders; Health Services Misuse; Humans; Intracranial Hypertension; Life Change Events; Magnetic Resonance Imaging; Male; Metoclopramide; Patient Education as Topic; Spinal Puncture; Substance-Related Disorders; Trigeminal Neuralgia; Vasoconstrictor Agents

2003
Episodic hypnic headache?
    Cephalalgia : an international journal of headache, 2004, Volume: 24, Issue:8

    Topics: Aged; Analgesics, Non-Narcotic; Caffeine; Central Nervous System Stimulants; Dihydroergotamine; Female; Headache Disorders; Humans; Lithium; Male; Sleep Wake Disorders

2004